Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price reached a new 52-week high on Thursday after JPMorgan Chase & Co. raised their price target on the stock from $10.00 to $14.00. JPMorgan Chase & Co. currently has a neutral rating on the stock. Vir Biotechnology traded as high as $14.45 and last traded […]

WELL Health Technologies Corp. (TSE:WELL – Get Free Report)’s share price reached a new 52-week high on Tuesday after Royal Bank of Canada raised their price target on the stock from C$7.00 to C$8.50. The company traded as high as C$7.30 and last traded at C$7.23, with a volume of 1354392 shares traded. The stock […]